Affiliate disclosure: Some links in this article are affiliate links. We may earn a commission at no additional cost to you.

Medical disclaimer: This article is for informational purposes only. It is not medical advice, diagnosis, or treatment. Not medical advice. Consult a qualified healthcare professional before changing your diet, exercise, or supplement regimen.

Japan’s national health promotion framework has operated under the “健康日本21” (Health Japan 21) label for over two decades. The third-generation plan — formally launched in April 2024 under Ministry of Health, Labour and Welfare (MHLW) authority and running through fiscal year 2032 — marks a structural shift from the previous two iterations: the headline target is no longer total life expectancy, but healthy life expectancy (健康寿命). That choice of primary metric, and what the framework actually measures to track progress against it, is the subject of this article.

A calibration note that applies throughout: Health Japan 21’s third phase is in its early stages as of mid-2026. The plan designates formal interim review cycles across the decade. What is currently available consists of the published policy framework and targets — documented in MHLW’s official third-phase materials — along with the baseline data drawn from the 2019 National Health and Nutrition Survey and related health statistics, and initial observations from MHLW annual survey cycles through 2024. Comprehensive measurable progress against the 2032 targets cannot be assessed at this point, and any source claiming otherwise should be read with that limitation in mind.

Why healthy life expectancy replaced total life expectancy as the primary target

Japan holds the highest total life expectancy among OECD nations — approximately 84.3 years in the most recent OECD Health Statistics figures. That number appears routinely in Japan-and-longevity coverage. Less often noted alongside it: the WHO estimates Japan’s healthy life expectancy at approximately 74.1 years. The resulting gap — roughly a decade lived with significant disease burden or functional limitation — is the policy problem that the third phase of Health Japan 21 is structured around.

The second phase (2013–2022) tracked 53 indicators across multiple health dimensions and produced mixed results: some behavioral indicators, including smoking rates and walking frequency in certain age groups, moved in targeted directions; others, including obesity rates in younger women and alcohol-related indicators, showed insufficient change relative to targets. An MHLW post-phase review published before the third phase launch noted that complex indicators requiring broad societal change had proven harder to shift than individual-behavioral measures. That finding directly shaped the third phase’s architectural decisions.

The third phase’s baseline for healthy life expectancy, drawn from 2019 data, is 72.68 years for men and 75.38 years for women. The framework sets a directional target to extend these figures — explicitly framing the objective as reducing the gap between total and healthy life expectancy, not simply extending total longevity further. The published MHLW framework names 健康寿命の延伸 (extending healthy life expectancy) and 健康格差の縮小 (narrowing health disparities across regions and socioeconomic groups) as coequal primary goals.

The third phase’s four measurement domains

The framework organizes its indicators across four top-level domains, each with subcategories carrying specific quantitative targets.

Domain 1: Healthy life expectancy and health disparities. This is the overarching output metric. The framework also measures prefecture-level healthy life expectancy disparity as a second indicator alongside the national figure, explicitly targeting a reduction in the gap between highest- and lowest-ranked prefectures. MHLW prefectural health data has historically shown significant variation — Nagano Prefecture has occupied top or near-top positions for both male and female life expectancy rankings for multiple successive cycles — and the third phase treats that geographic concentration of longevity as evidence of modifiable determinants rather than fixed regional characteristics.

Domain 2: Individual behaviors and health status. This domain carries the largest number of specific indicators and covers nutrition (daily vegetable and fruit intake, sodium reduction, caloric balance), physical activity (daily step count targets for multiple age groups), sleep adequacy, tobacco, and alcohol. Several second-phase targets in this domain were not met — average daily salt intake, for instance, remained above the third-phase target level at baseline. Salt intake is directly relevant to Japan’s documented longevity evidence base: MHLW’s published target is a population average of 7g/day (down from the 10.1g figure recorded in the most recent National Health and Nutrition Survey at the time of baseline establishment). The evidence linking sodium reduction to cardiovascular outcomes in Japanese cohort data — including prefectural trajectories like Nagano’s documented stroke mortality decline alongside its decades-long salt-reduction campaign — is one of the more coherent regional public health histories in MHLW tracking literature.

Domain 3: Prevention of lifestyle-related disease onset and progression. This domain covers the main non-communicable disease categories tracked in national health data: hypertension, dyslipidemia, diabetes, chronic kidney disease, cancer, and cardiovascular disease. For most of these categories, the third phase structures its targets around preventive screening uptake rates — with increased coverage goals for colorectal, cervical, breast, and gastric cancer screening programs — alongside specific biomarker improvement goals and progression-prevention metrics. These targets are grounded in what MHLW classifies as preventive medicine infrastructure: organized screening programs that constitute the mechanism by which higher screening penetration is expected to translate into earlier-stage detection and reduced progression to severe disease outcomes.

Domain 4: Quality of social environment. This is the most structurally distinctive addition relative to prior Health Japan 21 iterations and the domain most clearly responding to evidence that Japanese social structures are changing in ways that may not be favorable for healthy aging at the population level. The third phase includes specific indicators around social connections (measuring the proportion of adults who report meaningful relationships), natural capital access (walkable green space, neighborhood design features associated with sustained physical activity among older adults), and workplace and community health program coverage. OECD data places Japan in the lower third of member nations on self-reported social support availability — a figure that reads as incongruous alongside Japan’s aggregate longevity statistics and led to measurable policy responses including the government’s establishment of a Minister for Loneliness in 2021. The third phase’s inclusion of social environment as a tracked domain with quantitative targets reflects official acknowledgment that aggregate longevity data and social isolation trends are coexisting in a way that warrants policy attention.

2026 progress: what the early data suggests

The third phase is approximately two years old at mid-2026. National Health and Nutrition Survey data for 2023 and 2024 provides the closest available window on early indicator movement, though this survey measures behavioral and nutritional metrics rather than HALE directly. Formal healthy life expectancy calculations are produced on a different cycle — the next figure reflecting third-phase methodology is expected to draw on data from approximately 2025–2026, with publication likely in subsequent years.

On behavioral indicators, published 2023 survey data reflected some continuation of existing trends: smoking rates in adult males continued a multi-year decline consistent with prior Health Japan 21 momentum; daily step counts in middle-aged adults remained below targets in multiple age-group categories. Vegetable intake showed no significant improvement from the second-phase period baseline. Salt intake decline — a priority target across multiple Health Japan 21 iterations — has shown incremental movement in tracking surveys but remains above the third-phase target level.

The social environment domain presents the least mature measurement infrastructure. Several of the specific indicators in this domain are newly defined for the third phase, and baseline values are still being established across early survey cycles. The measurement framework appears operational based on MHLW’s 2023–2024 reporting, but trajectory data requires multiple years before direction becomes interpretable.

A structural observation worth making explicit: the gap between Health Japan 21 target periods and the timelines on which population-level health outcomes are actually measurable is inherent to this kind of policy framework. Setting a 2032 healthy life expectancy target in 2024 means the primary output metric can only be evaluated near the end of the plan. What midpoint reviews — expected around 2028–2029 — will assess is indicator-level movement, not HALE outcomes directly. This is not a design limitation unique to this framework; it reflects how long the causal chains between policy inputs and population-level health outcomes actually operate.

The social environment target and what distinguishes the third phase

For those following Japan’s longevity research from outside Japan, the fourth domain — social environment quality — is the most analytically novel aspect of the third phase, and the one with the least direct precedent in earlier Health Japan 21 iterations.

The framework’s targets in this area include increasing the proportion of adults reporting meaningful social relationships, expanding coverage of workplace health management programs under the 健康経営 (Health and Productivity Management) initiative, and improving community-level infrastructure for outdoor physical activity and social engagement among older adults.

These targets are grounded in a body of domestic research connecting social isolation to health outcomes in older Japanese adults. The moai network research from Okinawa’s centenarian cohorts, and the social-structure documentation from Kyotango’s research program at Kyoto Prefectural University of Medicine, both appear in the evidence base that informs this domain. Kyotango’s dense extended-family and neighborhood engagement patterns — associated with centenarian density approximately five times the national average — represent the kind of social structure the third phase is attempting to create policy conditions for at scale.

Whether organized policy mechanisms can move social connection rates in the way tobacco regulation has moved smoking rates is not established. The third phase represents a policy hypothesis: that structured incentives through employer programs, community design investment, and social engagement initiatives can shift the relevant indicators. Maintaining the distinction between policy hypothesis and documented outcome mechanism is useful when reading MHLW progress reports in this domain over the coming years.

What to read next

For the cross-national context behind Japan’s healthy life expectancy positioning — specifically how Japan’s HALE compares across OECD metrics and what the OECD’s own analyses associate with the gap — Japan in OECD Healthy Aging Data: A 2026 Reading covers the external-observer picture that Health Japan 21 addresses from the domestic policy side. The two articles are designed to complement each other: OECD data provides the comparative frame; the Health Japan 21 framework documents what Japan’s own policy apparatus is doing in response.

For the regional variation that underlies the prefecture-level disparity targets in the third phase — and the research documentation behind Nagano, Kyotango, and Okinawa as cohort outlier cases — Beyond Okinawa: Kyotango and Nagano reviews the longitudinal data from each.

For readers who want primary-source access: MHLW maintains the Health Japan 21 third phase documentation at the Ministry’s health promotion portal (in Japanese). English-language academic literature on the framework’s history includes several structured reviews in the International Journal of Environmental Research and Public Health, which has published analyses of the first and second phases with commentary on third-phase design changes.

For English-language books covering population health, preventive medicine approaches, and evidence-based health policy of the kind that informs frameworks like Health Japan 21 — Amazon carries a range of texts from public health and epidemiology authors working in this field.

---

Related reading: Japan in OECD Healthy Aging Data: A 2026 Reading | Beyond Okinawa: Kyotango and Nagano | Japan Longevity Research 2026: Annual Highlights